The authors suggest that distinctive glial lesions reflect alterations in tau isoform composition and cellular expression, but the specific relationships remain unclear. This knowledge gap prevents understanding of how tau variants drive disease-specific pathology and limits development of isoform-targeted therapies. Gap type: open_question Source paper: Tau-positive glial inclusions in progressive supranuclear palsy, corticobasal degeneration and Pick's disease. (1999, Brain pathology (Zurich, Switzerland), PMID:10517506)
Landscape Summary: How do tau isoform alterations specifically determine glial inclusion morphology and disease phenotype? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: open.
Colonna, Sevlever, et al. (TREM2 biology)
How do tau isoform alterations specifically determine glial inclusion morphology and disease phenotype? — INVOKE-2 (completed)
No hypotheses linked to this gap yet.
No knowledge graph edges recorded
No activity recorded yet.
No discussions yet. Be the first to comment.
Create sub-tasks to investigate specific aspects of this gap: